Replies to post #46155 on Biotech Values

[daved]

Re GNTA David: What an unfortunate mess.

Please explain "scenario" in this context:

"Genta presented the correct equations in their presentation. While the PFS benefit shrank to clinical insignificance in some situations, none of the scenarios (or none but the most outlandish differential assumption, I don't quite remember) failed to reach statistical significance.

Thx,
Dave

[daved]

The cards were all stacked against approval. Yuch. An inadvertant SPA trap okayed by the company. How unfortunate.

It seems to me that the contol arm should have been DTIC day 4, 29 & 54. Scans for both arms should have been 0 29 and 54.

Dave